Resource Centers
- Earlier and More Aggressive LDL Lowering, or Better Approaches for Targeting High-Risk Individuals?
- Direct Cardiotoxicity From Air Pollution Appreciated as Possible Hazard
- Many US Adults, Especially High-Risk Individuals, Not at Recommended Lipid Targets
- Recalls & Warnings FDA and Boston Scientific Recall NexStent Carotid Stent System
- Sulfonylureas and Metformin May Increase Risk for Cardiovascular Hospitalization
- Overall Healthy Lifestyle Significantly Reduces Stroke Risk
Cardiology Journals
- American Heart Journal
- British Journal of Cardiology
- European Heart Journal
- Expert Review of Cardiovascular Therapy
- Future Cardiology
- Journal of Cardiovascular Electrophysiology
- Journal of Invasive Cardiology
- Journal of the American College of Cardiology (JACC)
- Nature Clinical Practice Cardiovascular Medicine
Medscape Community Resources
- Blood Pressure, Diabetes, Gender, and Race -- What, When, How It Is, or Is Not, Treated
- Monitoring and Managing Cardiotoxicities Associated with Cancer Therapies: An Expert Interview with Dr. Pamela S. Douglas
- Which Diet is Best? Have the Behaviorists Failed Us?
- Should Statins Ever Be Prescribed in Children With Lipid Problems?
- Why Should I Report an Adverse Drug Event?
POLL
A new bill in Congress would send trained clinicians into doctors’ offices with independent data about the relative benefits, risks, and costs of drugs; some research suggests that such "academic detailing" reduces potential prescribing bias from the influence of drug company reps. What effect do you think such a program would have?
Cardiology CME
- A Change in Upper Extremity Examination
- Complications in Oncology Practice: Venous Thromboembolism and Tumor Lysis Syndrome
- Managing Type 2 Diabetes: Developing Office-based Systems of Care
- Analyze This Image: CW Recording From a 35-Year-Old Patient Complaining of Dyspnea and Fatigue
- Hyperemesis and Epigastric Pain in a 27-Year-Old Man
Advisory Board
Section Editors
Editorial Directors
